MAPK4 DEFINES A SUBSET OF TRIPLE-NEGATIVE BREAST CANCER VULNERABLE TO NOVEL TARGETED THERAPY

$1,188,750FY2017Department of the ArmyDOD

Baylor College Of Medicine, Houston TX

Investigators